Leveraging Circulating Tumor DNA to Optimize the Initial Management of Childhood Renal Tumors

J Clin Oncol. 2022 Sep 10;40(26):3006-3010. doi: 10.1200/JCO.22.00820. Epub 2022 Jul 5.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Biomarkers, Tumor / genetics
  • Circulating Tumor DNA* / genetics
  • Humans
  • Kidney Neoplasms* / genetics
  • Kidney Neoplasms* / pathology
  • Kidney Neoplasms* / therapy
  • Wilms Tumor* / genetics

Substances

  • Biomarkers, Tumor
  • Circulating Tumor DNA